Skip to content

Objective Research on the Four Diagnostic Methods of Traditional Chinese Medicine for Blood Stasis Syndrome in Coronary Heart Disease

Objective Research on the Four Diagnostic Methods of Traditional Chinese Medicine for Blood Stasis Syndrome in Coronary Heart Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002598
Enrollment
Unknown
Registered
2025-12-30
Start date
2025-10-08
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Coronary heart disease with blood stasis syndrome group:This study was an observational one with no intervention measures
coronary heart disease without blood stasis syndrome group:This study was an observational one with no intervention measures

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1)18 years old to 85 years old, gender not limited; (2) Consistent with the diagnosis of stable coronary heart disease; (3) People with coronary heart disease and blood stasis syndrome need to be diagnosed with coronary heart disease and blood stasis syndrome (including qi stagnation and blood stasis syndrome, qi deficiency and blood stasis syndrome, Yang deficiency and blood stasis syndrome, phlegm and blood stasis intermingle syndrome, and blood stasis and toxicity intermingle syndrome). (4) Sign the informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe diseases of the heart, brain, liver, kidneys and other systems; (2) Pregnant or lactating women; (3) Those who suffer from mental illness and are unable to cooperate with information collection; (4) Those who are unable to cooperate in the collection of information from the four diagnostic methods.

Design outcomes

Primary

MeasureTime frame
Coronary CT Angiography;echocardiography;carotid artery ultrasound;radial artery ultrasound;Total Cholesterol;Triglycerides;Low-Density Lipoprotein Cholesterol;Small Dense Low-Density Lipoprotein Cholesterol;High-Sensitivity C-Reactive Protein;Fibrinogen;Thrombin-Antithrombin complex;

Countries

China

Contacts

Public ContactLi Qiuyan

Xiyuan Hospital, China Academy of Chinese Medical Sciences

liqiuyan1968@sohu.com13701116996

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026